Date: 2016-05-10
Type of information: Company acquisition
Acquired company: Kuecept (UK)
Acquiring company: Aptuit (UK)
Amount: undisclosed
Terms: * On May, 10th, 2016, Aptuit announced that it has acquired Kuecept to meet strong customer demand for specialist drug pre-formulation, formulation prototyping and formulation development services. This acquisition will allow Aptuit to enhance its capabilities in the preformulation development area.
Details: Located in London, Kuecept offers industry leading technical expertise in CRO services supporting preclinical drug development. Kuecept provides pre-formulation testing, preclinical dose-vehicle screening and formulation development. These are complemented by a comprehensive range of enabling drug-delivery technologies. Kuecept has deep experience in respiratory, parenteral and oral formulation development for insoluble compounds. Formulation rescue consultancy helps companies move APIs through IND/CTA enabling safety assessment.
Related: Technology - Services
